étude a découvert – English Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot      41 Results   13 Domains
  24 Hits www.eurospapoolnews.com  
L’étude a découvert que la THCV réduisant significativement la glycémie à jeun et améliorait les fonctions cellulaires pancréatiques, alors que la combinaison CBD-THCV n’a eu aucun effet significatif sur les patients.
The study found that THCV significantly decreased fasting plasma glucose levels and improved pancreatic cell function, while the combination CBD-THCV treatments had no significant effect on patients.
  www.bikebiz.com  
La présente étude a découvert des associations entre la consommation intensive de marijuana et un risque accru d’événements cardiovasculaires chez les hommes âgés de 40 et à 60 ans. Cette augmentation était indépendante de la consommation de tabac.
The present study found associations between heavy marijuana use and an increased rate of cardiovascular events in men aged 40 to 60 years. This increase was independent of smoking tobacco.
  3 Hits www.cancer.ca  
Traitement du cancer du sein. Notre étude a découvert qu’une radiothérapie additionnelle réduit le risque de récidive chez les femmes ayant un cancer du sein au stade précoce et pourrait améliorer le taux de survie.
Treating breast cancer. Our study found that additional radiation treatment reduces risk of recurrence for women with early breast cancer and could increase survival.
  www.genderevaluation.net  
Fait surprenant, l'étude a découvert que seul un Simputer sur cinq parmi les sarpanchas interrogés fonctionnait. Ce chiffre se réduisait à un peu plus de un sur dix parmi les Simputers utilisés par les élues.
Dr. Anupama Saxena is currently working as an Associate Professor of Political Science and Director in-charge of Women’s Studies and Development Centre of Guru Ghasidas University, Bilaspur, Chhattisgarh, India (www.ggu.ac.in) and has been associated with the GEM project since 2005.
  www.nrcan.gc.ca  
L'étude a découvert que l'ICTTI est cohérente avec les priorités fédérales et qu'elle est pertinente dans la prestation de l'accès aux marchés et partenaires étrangers. Aussi, l'ICTTI est pertinente dans la présentation des capacités technologiques canadiennes et la facilitation du transport et de l'exportation de technologies.
The study found that CIITT is consistent with federal priorities and is relevant in providing access to foreign markets and partners. As well, CIITT is relevant in showcasing Canadian technological capabilities and facilitating technology transport and export.
  www.rncan.gc.ca  
L'étude a découvert que l'ICTTI est cohérente avec les priorités fédérales et qu'elle est pertinente dans la prestation de l'accès aux marchés et partenaires étrangers. Aussi, l'ICTTI est pertinente dans la présentation des capacités technologiques canadiennes et la facilitation du transport et de l'exportation de technologies.
The study found that CIITT is consistent with federal priorities and is relevant in providing access to foreign markets and partners. As well, CIITT is relevant in showcasing Canadian technological capabilities and facilitating technology transport and export.
  www.apc.org  
L’étude a découvert que le câble SAT-3/WASC n’a pas tenu ses promesses du fait de sa structure de propriété et des aspects anti-concurrentiels du contrat entre les signataires. Et bien que certaines réformes réglementaires aient transformé la structure du marché depuis 2002, le câble demeure encore sous-utilisé du fait des arrangements commerciaux entre les signataires.
The study found that the SAT-3/WASC cable has not met its potential due to its ownership structure and the anti-competitive aspects of the agreement between the signatories. And although some regulatory reform has changed the market structure since 2002, the cable still remains under-utilised due to the commercial arrangement amongst the signatories.
  2 Hits hc-sc.gc.ca  
Une autre étude a découvert que 4 participantes sur 62 ont rapporté des saignements vaginaux pendant les 3 mois où elles consommaient 114 mg d'isoflavones de soya par jour, quoique globalement aucun effet significatif n'ait été détecté pour les variables mesurées au niveau de l'endomètre (Nikander et coll. 2005).
In addition to the studies by Unfer et al. (2004) and Murray et al. (2003), there have been select case studies documenting gynaecological abnormalities in women who have reported high soy consumption. Noel et al. (2006) reported on a 75-year-old woman who consumed 72 mg/day of 'super-concentrated' soy isoflavones (AIE not reported) for 5 years and developed a ureteral malignant mullerian carcinosarcoma in a context of florid endometriosis. The patient had a history of total hysterectomy with bilateral salpingo-oophorectomy 30 years earlier for extensive endometriosis. This is the first case of ureteral mullerian carcinosarcoma arising in endometriosis foci after extensive phytoestrogen supplementation and the data suggest that soy isoflavones (at least in concentrated form) may play a role not only in maintenance of endometriosis but also in its malignant transformation. More recently, Chandrareddy et al. (2008) documented 3 cases that linked intake of soy products (including soy beverage, soy protein concentrate, tofu and soy baloney) with endometrial pathologies including a case of postmenopausal bleeding with uterine polyp, proliferative endometrium and a growing leiomyoma; a case of severe dysmenorrhea, abnormal uterine bleeding, endometriosis and uterine leiomyoma not responding to treatment; and a case of severe dysmenorrhea, abnormal uterine bleeding, endometriosis, uterine leiomyomata and secondary infertility. All three women improved after withdrawal of soy from their diet and the authors concluded that additional information about the safety of phytoestrogen supplementation is required before they can be routinely used. Finally, most recently, Cecchi et al. (2009) reported that a 52-year old Caucasian postmenopausal woman who took soy isoflavones (dose not stated) for 4 months presented with high serum levels of CA 19-9 (66 U/mL, normal range 0-37 U/mL) and upon stopping supplementation, her CA 19-9 returned to normal within one month. Prior to this, the woman had initially presented with a slight enlargement of the right ovary and uterine fibromyomatosis while on HRT. These findings are relevant as CA 19-9 is a carbohydrate marker of neoplastic disease, and it offers high sensitivity for the mucinous histotype of ovarian carcinoma.
  2 Hits www.hc-sc.gc.ca  
Une autre étude a découvert que 4 participantes sur 62 ont rapporté des saignements vaginaux pendant les 3 mois où elles consommaient 114 mg d'isoflavones de soya par jour, quoique globalement aucun effet significatif n'ait été détecté pour les variables mesurées au niveau de l'endomètre (Nikander et coll. 2005).
In addition to the studies by Unfer et al. (2004) and Murray et al. (2003), there have been select case studies documenting gynaecological abnormalities in women who have reported high soy consumption. Noel et al. (2006) reported on a 75-year-old woman who consumed 72 mg/day of 'super-concentrated' soy isoflavones (AIE not reported) for 5 years and developed a ureteral malignant mullerian carcinosarcoma in a context of florid endometriosis. The patient had a history of total hysterectomy with bilateral salpingo-oophorectomy 30 years earlier for extensive endometriosis. This is the first case of ureteral mullerian carcinosarcoma arising in endometriosis foci after extensive phytoestrogen supplementation and the data suggest that soy isoflavones (at least in concentrated form) may play a role not only in maintenance of endometriosis but also in its malignant transformation. More recently, Chandrareddy et al. (2008) documented 3 cases that linked intake of soy products (including soy beverage, soy protein concentrate, tofu and soy baloney) with endometrial pathologies including a case of postmenopausal bleeding with uterine polyp, proliferative endometrium and a growing leiomyoma; a case of severe dysmenorrhea, abnormal uterine bleeding, endometriosis and uterine leiomyoma not responding to treatment; and a case of severe dysmenorrhea, abnormal uterine bleeding, endometriosis, uterine leiomyomata and secondary infertility. All three women improved after withdrawal of soy from their diet and the authors concluded that additional information about the safety of phytoestrogen supplementation is required before they can be routinely used. Finally, most recently, Cecchi et al. (2009) reported that a 52-year old Caucasian postmenopausal woman who took soy isoflavones (dose not stated) for 4 months presented with high serum levels of CA 19-9 (66 U/mL, normal range 0-37 U/mL) and upon stopping supplementation, her CA 19-9 returned to normal within one month. Prior to this, the woman had initially presented with a slight enlargement of the right ovary and uterine fibromyomatosis while on HRT. These findings are relevant as CA 19-9 is a carbohydrate marker of neoplastic disease, and it offers high sensitivity for the mucinous histotype of ovarian carcinoma.